[{"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-001", "question": "A 45-year-old woman presents with progressive bilateral hearing loss, facial numbness, and ataxia. MRI reveals bilateral enhancing cerebellopontine angle masses with significant brainstem compression. Genetic testing confirms a missense mutation in the SMARCB1 gene. After maximal safe resection of the larger tumor, which management strategy offers the best long-term tumor control while preserving neurological function?", "options": ["Treatment with a selective histone deacetylase 6 (HDAC6) inhibitor", "Initiation of mTOR complex 1/2 dual inhibitor therapy", "Conformal radiotherapy targeting both lesions with dose painting", "Observation with serial MRI and consideration of bevacizumab for symptom control", "Prophylactic ventriculoperitoneal shunting followed by chemotherapy with carboplatin/vincristine"], "answer": "A", "answer_index": 0, "explanation": "The clinical scenario describes schwannomatosis due to SMARCB1 mutation. HDAC6 inhibitors have shown specific efficacy in preclinical models of SMARCB1-deficient tumors by restoring protein homeostasis and inducing apoptosis, unlike broader epigenetic modifiers. mTOR inhibitors are more relevant for NF2-related schwannomas, while radiotherapy is contraindicated in schwannomatosis due to malignant transformation risk. Bevacizumab has limited efficacy in SMARCB1-mutant tumors compared to NF2-mutant schwannomas.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V. Verdict: Correct best answer. Key stem clues: progressive bilateral CPA masses, SMARCB1 missense mutation, brainstem compression, post–maximal resection. The question asks for the best long-term tumor-preserving strategy for this condition in this patient. The keyed answer A (HDAC6 inhibitor) is defensible because the rationale correctly states that HDAC6 inhibition specifically targets SMARCB1-deficient tumors in preclinical models, whereas mTOR inhibitors are NF2‑associated, radiotherapy is contraindicated, bevacizumab has limited SMARCB1 efficacy, and chemotherapy is nonstandard. No internal contradictions; the genetic marker uniquely points to the targeted option, allowing a single best choice. Medical accuracy: The genetics and mechanistic rationale are correct, but the item frames an investigational agent as the preferred management without noting the lack of clinical trial data, which may misrepresent current standard of care (surgery ± observation). Minor nuance omitted. Minimal fix: Append 'based on emerging preclinical evidence' to the stem or answer A to clarify investigational status.\",\n\"medical_accuracy_score\":   \t\"3\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. Key stem clues: progressive bilateral CPA masses, SMARCB1 missense mutation, brainstem compression, post–maximal resection. The question asks for the best long-term tumor-preserving strategy for this condition in this patient. The keyed answer A (HDAC6 inhibitor) is defensible because the rationale correctly states that HDAC6 inhibition specifically targets SMARCB1-deficient tumors in preclinical models, whereas mTOR inhibitors are NF2‑associated, radiotherapy is contraindicated, bevacizumab has limited SMARCB1 efficacy, and chemotherapy is nonstandard. No internal contradictions; the genetic marker uniquely points to the targeted option, allowing a single best choice. Medical accuracy: The genetics and mechanistic rationale are correct, but the item frames an investigational agent as the preferred management without noting the lack of clinical trial data, which may misrepresent current standard of care (surgery ± observation). Minor nuance omitted. Minimal fix: Append 'based on emerging preclinical evidence' to the stem or answer A to clarify investigational status.", "medical_accuracy_score": 3, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-002", "question": "A 68-year-old man with locally advanced pancreatic cancer involving the celiac axis undergoes stereotactic body radiotherapy (SBRT) to 40 Gy in 5 fractions. Three months later, he develops severe epigastric pain and hematemesis. Endoscopy reveals a deeply ulcerated lesion in the gastric antrum with visible vessel. Biopsy shows radiation-induced changes without malignancy. Which interventional approach is most likely to achieve durable hemostasis while minimizing the risk of gastric perforation?", "options": ["Over-the-scope clip placement with concomitant fibrin glue injection", "Hybrid argon plasma coagulation combined with topical hemostatic powder", "Selective angiography with coil embolization of the gastroduodenal artery", "Endoscopic ultrasound-guided cyanoacrylate injection into the peri-ulcer bed", "Temporary covered esophageal stent placement with nasojejunal feeding tube"], "answer": "D", "answer_index": 3, "explanation": "After high-dose SBRT, conventional endoscopic therapies often fail due to compromised tissue healing. EUS-guided cyanoacrylate injection directly targets the feeding vessel deep within the ulcer bed, creating a permanent seal without the tissue disruption caused by thermal modalities. Over-the-scope clips may not hold in friable irradiated tissue, while angiographic embolization risks non-target ischemia. Topical agents provide only temporary control in this high-flow scenario.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: K (miskeyed). Verdict: The keyed answer D is not the best. Key stem clues: radiation-induced gastric ulcer with visible vessel after SBRT, tissue friable, need for durable hemostasis with minimal perforation risk. Main logical issue: The item incorrectly identifies EUS-guided cyanoacrylate injection as the optimal intervention; however, angiographic coil embolization (C) offers durable hemostasis with negligible direct perforation risk and is the accepted salvage therapy for refractory ulcer bleeding in irradiated tissue. The explanation’s claim that cyanoacrylate avoids tissue disruption is unsupported; injection can cause necrosis and perforation. Medical accuracy: D reflects a nonstandard, evidence‑sparse approach; current guidelines favor embolization when endoscopic therapy is unlikely to succeed. Thus the item misleads learners. Minimal fix: Re‑key to C and update rationale to highlight embolization’s high success rate and low perforation risk, noting that EUS‑guided injection remains investigational.\",\n\"medical_accuracy_score\":   \t\"2\",\n\"logical_validity\": false,\n\"logical_false_reason\": \"K\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (miskeyed). Verdict: The keyed answer D is not the best. Key stem clues: radiation-induced gastric ulcer with visible vessel after SBRT, tissue friable, need for durable hemostasis with minimal perforation risk. Main logical issue: The item incorrectly identifies EUS-guided cyanoacrylate injection as the optimal intervention; however, angiographic coil embolization (C) offers durable hemostasis with negligible direct perforation risk and is the accepted salvage therapy for refractory ulcer bleeding in irradiated tissue. The explanation’s claim that cyanoacrylate avoids tissue disruption is unsupported; injection can cause necrosis and perforation. Medical accuracy: D reflects a nonstandard, evidence‑sparse approach; current guidelines favor embolization when endoscopic therapy is unlikely to succeed. Thus the item misleads learners. Minimal fix: Re‑key to C and update rationale to highlight embolization’s high success rate and low perforation risk, noting that EUS‑guided injection remains investigational.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-003", "question": "A 52-year-old man undergoes right pneumonectomy for T3N2M0 non-small cell lung cancer. On postoperative day 4, he develops acute respiratory distress. Chest tube output abruptly decreases, and the mediastinum shifts toward the left on radiograph. Bronchoscopy reveals a 1.5 cm dehiscence of the bronchial stump without frank disruption. What is the most appropriate immediate management?", "options": ["Emergency rethoracotomy with direct stump revision", "Placement of a second chest tube to water seal", "Immediate bedside reopening of the incision with antibiotic irrigation", "Flexible bronchoscopic placement of an endobronchial valve in the right main bronchus", "Urgent veno-venous ECMO cannulation followed by operative repair"], "answer": "C", "answer_index": 2, "explanation": "This scenario describes a post-pneumonectomy bronchopleural fistula with impending tension physiology. Immediate bedside reopening allows mediastinal decompression and converts the situation to an open pleural cavity, preventing fatal tension. This is followed by formal operative repair after stabilization. Endobronchial valves are ineffective for large proximal dehiscences. Re-thoracotomy without decompression risks cardiovascular collapse. ECMO is reserved for refractory respiratory failure after initial stabilization.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Thoracic Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V. Verdict: The keyed answer (C) is the correct best answer. Key stem clues: post‑pneumonectomy day 4, acute respiratory distress, abrupt decrease in chest‑tube output, leftward mediastinal shift, and bronchoscopic demonstration of a 1.5‑cm bronchial stump dehiscence. These findings together indicate a large bronchopleural fistula with tension physiology. The immediate priority is mediastinal decompression, which is achieved by bedside reopening of the thoracotomy incision; this converts the closed pneumonectomy space into an open cavity, relieving tension and allowing subsequent definitive repair. Alternative options are inferior: re‑thoracotomy without prior decompression risks cardiovascular collapse (A), a second chest tube cannot decompress the mediastinum (B), an endobronchial valve is ineffective for a large proximal defect (D), and ECMO is reserved for refractory respiratory failure after initial stabilization (E). No internal contradictions or missing details prevent selection of a single best answer. Medical accuracy: The recommended immediate management aligns with current thoracic surgery guidelines. Minimal fix: None required; the item is clear and unambiguous.\",\n\"medical_accuracy_score\":  \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: The keyed answer (C) is the correct best answer. Key stem clues: post‑pneumonectomy day 4, acute respiratory distress, abrupt decrease in chest‑tube output, leftward mediastinal shift, and bronchoscopic demonstration of a 1.5‑cm bronchial stump dehiscence. These findings together indicate a large bronchopleural fistula with tension physiology. The immediate priority is mediastinal decompression, which is achieved by bedside reopening of the thoracotomy incision; this converts the closed pneumonectomy space into an open cavity, relieving tension and allowing subsequent definitive repair. Alternative options are inferior: re‑thoracotomy without prior decompression risks cardiovascular collapse (A), a second chest tube cannot decompress the mediastinum (B), an endobronchial valve is ineffective for a large proximal defect (D), and ECMO is reserved for refractory respiratory failure after initial stabilization (E). No internal contradictions or missing details prevent selection of a single best answer. Medical accuracy: The recommended immediate management aligns with current thoracic surgery guidelines. Minimal fix: None required; the item is clear and unambiguous.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-004", "question": "A 74-year-old man with a history of abdominal aortic aneurysm repair presents with acute onset of painful blue discoloration of his toes despite palpable pedal pulses. Laboratory studies show elevated creatinine kinase and acute kidney injury. Angiography demonstrates patent bypass graft but diffuse microvascular occlusion in both feet. What is the most appropriate emergent intervention?", "options": ["Immediate bilateral sympathectomy", "Systemic heparinization followed by catheter-directed thrombolysis", "High-dose corticosteroid pulse therapy", "Emergent surgical embolectomy of the tibial vessels", "Plasma exchange with albumin replacement"], "answer": "E", "answer_index": 4, "explanation": "The presentation is consistent with cholesterol embolization syndrome following aortic manipulation. Plasma exchange removes inflammatory mediators and cholesterol-laden microemboli, improving microcirculatory flow. Thrombolysis is ineffective for cholesterol crystals and increases hemorrhage risk. Sympathectomy helps vasospasm but doesn't address the embolic load. Corticosteroids may modestly reduce inflammation but don't remove emboli. Surgical embolectomy cannot access distal microvasculature.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Vascular Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem’s key clues—acute blue toe syndrome after aortic surgery, palpable pulses, elevated CK, AKI, and angiographic diffuse microvascular occlusion—point to cholesterol embolization syndrome. Among the options, only plasma exchange (E) targets cholesterol microemboli; the others are either ineffective (thrombolysis, steroids), impractical (surgical embolectomy), or irrelevant (sympathectomy). Thus the item discriminates to a single best choice and the key matches it. Logical issues: None; the vignette is internally consistent and allows clear differentiation. Medical accuracy: The answer overstates the role of plasma exchange. Current guidelines do not endorse plasma exchange as standard emergent therapy for cholesterol embolization; management focuses on supportive care, discontinuing anticoagulation, and addressing renal failure. Presenting plasma exchange as the definitive emergent intervention may mislead learners. Minimal fix: Replace option E with \\\"Discontinue anticoagulation and initiate supportive care (IV fluids, statin, avoid further invasive procedures)\\\" and set that as the correct answer.\",\n\"medical_accuracy_score\":  \t \t \t \t \t \t \t \t \t \t\"2\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem’s key clues—acute blue toe syndrome after aortic surgery, palpable pulses, elevated CK, AKI, and angiographic diffuse microvascular occlusion—point to cholesterol embolization syndrome. Among the options, only plasma exchange (E) targets cholesterol microemboli; the others are either ineffective (thrombolysis, steroids), impractical (surgical embolectomy), or irrelevant (sympathectomy). Thus the item discriminates to a single best choice and the key matches it. Logical issues: None; the vignette is internally consistent and allows clear differentiation. Medical accuracy: The answer overstates the role of plasma exchange. Current guidelines do not endorse plasma exchange as standard emergent therapy for cholesterol embolization; management focuses on supportive care, discontinuing anticoagulation, and addressing renal failure. Presenting plasma exchange as the definitive emergent intervention may mislead learners. Minimal fix: Replace option E with \"Discontinue anticoagulation and initiate supportive care (IV fluids, statin, avoid further invasive procedures)\" and set that as the correct answer.", "medical_accuracy_score": 2, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-005", "question": "A 38-year-old woman with Crohn's disease maintained on vedolizumab presents with recurrent episodes of postprandial abdominal pain and 15-pound weight loss. CT enterography shows patent superior mesenteric artery and vein. Gastric emptying study is normal. Diagnostic laparoscopy reveals no adhesions. Which test will most likely establish the diagnosis?", "options": ["Mesenteric Doppler ultrasound with a standardized meal challenge", "Lactulose hydrogen breath test for small intestinal bacterial overgrowth", "Serum tryptase level during symptomatic episode", "Selective mesenteric angiography with vasodilator challenge", "Video capsule endoscopy with patency capsule confirmation"], "answer": "A", "answer_index": 0, "explanation": "This presentation suggests chronic mesenteric ischemia despite patent gross vasculature, possibly from vedolizumab-associated microvascular dysfunction. Provocative mesenteric Doppler can demonstrate reduced postprandial flow reserve. While bacterial overgrowth is common in Crohn's, it doesn't explain the postprandial timing. Angiography shows macrovascular disease already ruled out. Capsule endoscopy may show mucosal changes but doesn't assess flow dynamics. Tryptase would indicate mast cell disorder, which is less likely.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: U (Underspecified). Verdict: Not uniquely determinable. The stem describes postprandial pain and weight loss with patent mesenteric vessels, suggesting chronic mesenteric ischemia from microvascular disease. However, the vedolizumab-associated microvascular dysfunction mechanism is speculative and unsupported by literature. Key clues (postprandial pain, patent macrovasculature, normal gastric emptying) require assuming an unstated drug effect to justify microvascular ischemia. Alternative B (SIBO testing) is highly plausible in immunosuppressed Crohn's patients and could explain postprandial symptoms, creating a near-tie. While option A (mesenteric Doppler with meal challenge) is a legitimate test for chronic mesenteric ischemia, its application to vedolizumab-related microvascular disease is nonstandard. Medical accuracy is compromised by presenting an undocumented drug adverse effect as the central mechanism. Minimal fix: Replace vedolizumab with a drug known to cause vasculitis (e.g., azathioprine) or add objective evidence of microvascular disease (e.g., skin biopsy) to make the diagnosis defensible.\",\n\"medical_accuracy_score\":   \t\"3\",\n\"logical_validity\": false,\n\"logical_false_reason\": \"U\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: U (Underspecified). Verdict: Not uniquely determinable. The stem describes postprandial pain and weight loss with patent mesenteric vessels, suggesting chronic mesenteric ischemia from microvascular disease. However, the vedolizumab-associated microvascular dysfunction mechanism is speculative and unsupported by literature. Key clues (postprandial pain, patent macrovasculature, normal gastric emptying) require assuming an unstated drug effect to justify microvascular ischemia. Alternative B (SIBO testing) is highly plausible in immunosuppressed Crohn's patients and could explain postprandial symptoms, creating a near-tie. While option A (mesenteric Doppler with meal challenge) is a legitimate test for chronic mesenteric ischemia, its application to vedolizumab-related microvascular disease is nonstandard. Medical accuracy is compromised by presenting an undocumented drug adverse effect as the central mechanism. Minimal fix: Replace vedolizumab with a drug known to cause vasculitis (e.g., azathioprine) or add objective evidence of microvascular disease (e.g., skin biopsy) to make the diagnosis defensible.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-006", "question": "A 65-year-old man presents with acute severe hematochezia. Colonoscopy reveals active bleeding from a non-ulcerated lesion in the ascending colon with a visible vessel. Biopsy shows dilated submucosal veins without evidence of vasculitis or neoplasia. CT angiography shows no arterial malformation. What is the most appropriate endoscopic therapy?", "options": ["Heater probe coagulation with high power settings", "Endoscopic band ligation of the lesion", "Injection of N-butyl-2-cyanoacrylate glue", "Placement of through-the-scope clips in a circumferential pattern", "Argon plasma coagulation with extended application time"], "answer": "B", "answer_index": 1, "explanation": "The findings are characteristic of Dieulafoy's lesion of the colon, which involves a abnormally large submucosal artery. Endoscopic band ligation is superior to thermal or clipping methods as it mechanically secures the vessel with low recurrence rates. Cyanoacrylate injection risks embolization in this location. Thermal methods may not adequately coagulate the large caliber vessel. Clips may not achieve full-thickness compression needed for this lesion type.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: C (Contradiction). Verdict on keyed answer: Not uniquely determinable. Key stem clues: acute severe hematochezia; colonoscopy shows active bleeding from a non‑ulcerated ascending colon lesion with a visible vessel; biopsy reveals dilated submucosal veins; CT angiography shows no arterial malformation. These findings describe a venous lesion (colonic varix) rather than an arterial Dieulafoy lesion. The explanation, however, incorrectly identifies the lesion as a Dieulafoy lesion with a large submucosal artery, creating an internal inconsistency. Because the pathology is ambiguous, the item does not allow a single best answer to be defended; band ligation (choice B) is reasonable for a varix, but the rationale is flawed, and other options (e.g., clips, glue) could also be argued. Main logical issue: contradictory description of the lesion (veins vs artery) makes the stem internally inconsistent. Main medical accuracy issue: mischaracterization of Dieulafoy lesion as venous and incorrect justification for band ligation. Minimal fix: revise the biopsy description to \\\"dilated submucosal artery\\\" and align CT findings accordingly, or keep the venous description and rewrite the explanation to state that band ligation is effective for colonic varices.\",\n\"medical_accuracy_score\":  \t \t \t\"2\",\n\"logical_validity\": false,\n\"logical_false_reason\": \"C\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: C (Contradiction). Verdict on keyed answer: Not uniquely determinable. Key stem clues: acute severe hematochezia; colonoscopy shows active bleeding from a non‑ulcerated ascending colon lesion with a visible vessel; biopsy reveals dilated submucosal veins; CT angiography shows no arterial malformation. These findings describe a venous lesion (colonic varix) rather than an arterial Dieulafoy lesion. The explanation, however, incorrectly identifies the lesion as a Dieulafoy lesion with a large submucosal artery, creating an internal inconsistency. Because the pathology is ambiguous, the item does not allow a single best answer to be defended; band ligation (choice B) is reasonable for a varix, but the rationale is flawed, and other options (e.g., clips, glue) could also be argued. Main logical issue: contradictory description of the lesion (veins vs artery) makes the stem internally inconsistent. Main medical accuracy issue: mischaracterization of Dieulafoy lesion as venous and incorrect justification for band ligation. Minimal fix: revise the biopsy description to \"dilated submucosal artery\" and align CT findings accordingly, or keep the venous description and rewrite the explanation to state that band ligation is effective for colonic varices.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-007", "question": "A 55-year-old man with autosomal dominant polycystic kidney disease (ADPKD) and estimated glomerular filtration rate of 35 mL/min/1.73m² presents with acute left flank pain. CT shows a 8cm left renal cyst with hyperdense material and a fluid-debris level. Urinalysis shows 25-50 white blood cells but no bacteria. He is afebrile with normal blood pressure. What is the most appropriate management?", "options": ["Immediate initiation of ciprofloxacin", "Percutaneous drainage with cyst fluid culture", "CT-guided aspiration for cytology", "Hospital admission for intravenous ampicillin-sulbactam", "Analgesia and follow-up imaging in 4-6 weeks"], "answer": "B", "answer_index": 1, "explanation": "This presentation suggests an infected renal cyst in ADPKD, which requires drainage for both diagnosis and therapy. Cyst infections often present with minimal systemic signs in ADPKD patients. Antibiotics alone penetrate cysts poorly. Percutaneous drainage confirms the diagnosis, provides targeted therapy, and prevents sepsis. Aspiration for cytology would miss infection. Observation risks abscess formation. IV antibiotics without drainage are unlikely to eradicate the infection.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Nephrology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: M (U leading to M). Verdict: Not uniquely determinable. The stem describes an ADPKD patient with acute flank pain and an 8cm cyst containing hyperdense material and a fluid-debris level. While 25-50 urine WBCs suggest inflammation, the patient is afebrile with normal blood pressure—a critical missing discriminator, as fever is the most sensitive sign of cyst infection. This ambiguity allows two competing interpretations: hemorrhagic cyst (best managed with analgesia/follow-up, Option E) versus infected cyst (requiring drainage, Option B). The CT description lacks key details (e.g., wall enhancement, Hounsfield units) that would clarify etiology. Thus, multiple options are defensible based on reasonable clinical assumptions. Medical accuracy: The scenario is plausible but atypical; afebrile cyst infection is uncommon. The rationale's statement that antibiotics penetrate cysts poorly is outdated—fluoroquinolones achieve excellent cyst concentrations. Minimal fix: Add fever >38°C or specify CT findings of infection (rim enhancement, gas, HU >30) to establish infection as the clear diagnosis, making drainage unambiguously correct.\",\"medical_accuracy_score\":   \"3\",\"logical_validity\": false,\"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: M (U leading to M). Verdict: Not uniquely determinable. The stem describes an ADPKD patient with acute flank pain and an 8cm cyst containing hyperdense material and a fluid-debris level. While 25-50 urine WBCs suggest inflammation, the patient is afebrile with normal blood pressure—a critical missing discriminator, as fever is the most sensitive sign of cyst infection. This ambiguity allows two competing interpretations: hemorrhagic cyst (best managed with analgesia/follow-up, Option E) versus infected cyst (requiring drainage, Option B). The CT description lacks key details (e.g., wall enhancement, Hounsfield units) that would clarify etiology. Thus, multiple options are defensible based on reasonable clinical assumptions. Medical accuracy: The scenario is plausible but atypical; afebrile cyst infection is uncommon. The rationale's statement that antibiotics penetrate cysts poorly is outdated—fluoroquinolones achieve excellent cyst concentrations. Minimal fix: Add fever >38°C or specify CT findings of infection (rim enhancement, gas, HU >30) to establish infection as the clear diagnosis, making drainage unambiguously correct.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-008", "question": "A 28-year-old woman develops recurrent sinopulmonary infections and bronchiectasis. Workup reveals absent IgA, markedly reduced IgG and IgM, and absent B cells on flow cytometry. Genetic testing identifies a mutation in the λ5 surrogate light chain gene. Which specific immunological abnormality explains her infection pattern?", "options": ["Failure of heavy chain rearrangement in pre-B cells", "Defective VDJ recombination due to RAG deficiency", "Absence of the pre-B cell receptor complex signaling", "Mutation in the BLNK adapter protein preventing PLCγ activation", "Loss of BTK enzyme function disrupting B cell maturation"], "answer": "C", "answer_index": 2, "explanation": "The λ5 gene encodes part of the surrogate light chain critical for pre-B cell receptor formation. Without functional pre-BCR signaling, B cells fail to proliferate and mature at the pre-B cell stage, causing the arrested development seen here. This is distinct from Bruton's tyrosine kinase deficiency (which affects later signaling) or RAG deficiencies (which impair initial recombination). The specific λ5 mutation explains the profound B cell deficiency and hypogammaglobulinemia.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Immunology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V (Valid). Verdict: Correct best answer. Key stem clues: recurrent sinopulmonary infections, bronchiectasis, absent IgA, markedly reduced IgG/IgM, absent B cells, λ5 mutation. These point to a block in early B-cell development at the pre-B stage due to defective surrogate light chain. Option C directly links λ5 loss to absent pre-BCR signaling, which arrests B-cell maturation and explains the phenotype. Alternative options are incorrect: A (heavy-chain rearrangement occurs before λ5-dependent pre-BCR assembly), B (RAG deficiency would also impair T cells and cause SCID), D (BLNK acts downstream of pre-BCR), and E (BTK deficiency is a later block with a different genetic cause). No internal contradictions or missing critical details; the vignette uniquely selects C. Medical accuracy: The λ5 mutation is a known rare cause of autosomal recessive agammaglobulinemia; the pathophysiology is correctly described and distinguishes from BTK and RAG defects. No safety concerns. Minimal fix: None required; item is board-ready.\",\n\"medical_accuracy_score\":   \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict: Correct best answer. Key stem clues: recurrent sinopulmonary infections, bronchiectasis, absent IgA, markedly reduced IgG/IgM, absent B cells, λ5 mutation. These point to a block in early B-cell development at the pre-B stage due to defective surrogate light chain. Option C directly links λ5 loss to absent pre-BCR signaling, which arrests B-cell maturation and explains the phenotype. Alternative options are incorrect: A (heavy-chain rearrangement occurs before λ5-dependent pre-BCR assembly), B (RAG deficiency would also impair T cells and cause SCID), D (BLNK acts downstream of pre-BCR), and E (BTK deficiency is a later block with a different genetic cause). No internal contradictions or missing critical details; the vignette uniquely selects C. Medical accuracy: The λ5 mutation is a known rare cause of autosomal recessive agammaglobulinemia; the pathophysiology is correctly described and distinguishes from BTK and RAG defects. No safety concerns. Minimal fix: None required; item is board-ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-009", "question": "A 42-year-old immigrant from rural Venezuela presents with progressive dyspnea and hemoptysis. Echocardiography shows severe pulmonary hypertension with right ventricular hypertrophy. Serology is positive for Strongyloides stercoralis antibodies. CT chest reveals diffuse ground-glass opacities with bronchial wall thickening. What is the most appropriate initial treatment?", "options": ["Ivermectin alone", "Ivermectin plus prednisone", "Albendazole plus diethylcarbamazine", "Praziquantel followed by ivermectin", "Thiabendazole with gradual pulmonary vasodilator therapy"], "answer": "B", "answer_index": 1, "explanation": "This presentation suggests Strongyloides hyperinfection syndrome with associated pulmonary involvement. Treatment requires both anthelminthic therapy (ivermectin) and corticosteroids to prevent lethal inflammatory response from dying larvae (paradoxical worsening). Using ivermectin alone risks fatal inflammatory reaction. Albendazole is less effective for Strongyloides. Praziquantel treats schistosomiasis, not strongyloidiasis. Vasodilators don't address the underlying parasitic infection.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Infectious Disease", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: U (Underspecified). The stem lacks critical detail about hyperinfection severity to justify steroids. While positive Strongyloides serology with pulmonary findings suggests hyperinfection syndrome, the indication for concurrent prednisone (preventing 'lethal inflammatory response') is not explicitly supported by clinical data in the vignette. 'Severe pulmonary hypertension' is an atypical, unexplained finding that confounds the scenario. Verdict: Not uniquely determinable. Key clues driving the intended answer are positive serology and pulmonary involvement, but these equally support ivermectin monotherapy (Option A), which remains standard of care per CDC guidelines. The steroid rationale represents a nonstandard, controversial practice that could mislead learners. Options C, D, and E are clearly incorrect (wrong drug classes). Medical accuracy is compromised by promoting steroid use without established indication and including clinically implausible pulmonary hypertension. Minor fix: Revise stem to specify 'hyperinfection syndrome with diffuse alveolar hemorrhage' and delete pulmonary hypertension, or change key to A and rewrite rationale to reflect standard ivermectin monotherapy as initial treatment.\",\"medical_accuracy_score\":    \"2\",\"logical_validity\": false,\"logical_false_reason\": \"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: U (Underspecified). The stem lacks critical detail about hyperinfection severity to justify steroids. While positive Strongyloides serology with pulmonary findings suggests hyperinfection syndrome, the indication for concurrent prednisone (preventing 'lethal inflammatory response') is not explicitly supported by clinical data in the vignette. 'Severe pulmonary hypertension' is an atypical, unexplained finding that confounds the scenario. Verdict: Not uniquely determinable. Key clues driving the intended answer are positive serology and pulmonary involvement, but these equally support ivermectin monotherapy (Option A), which remains standard of care per CDC guidelines. The steroid rationale represents a nonstandard, controversial practice that could mislead learners. Options C, D, and E are clearly incorrect (wrong drug classes). Medical accuracy is compromised by promoting steroid use without established indication and including clinically implausible pulmonary hypertension. Minor fix: Revise stem to specify 'hyperinfection syndrome with diffuse alveolar hemorrhage' and delete pulmonary hypertension, or change key to A and rewrite rationale to reflect standard ivermectin monotherapy as initial treatment.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-010", "question": "A 65-year-old liver transplant recipient on tacrolimus, mycophenolate, and prednisone presents with altered mental status and focal neurological deficits. MRI shows multiple ring-enhancing lesions with eccentric target sign. CSF PCR is positive for JC virus. What is the most appropriate management?", "options": ["Reduce immunosuppression and initiate intravenous cidofovir", "Immediate exchange transfusion to reduce tacrolimus levels", "Switch from mycophenolate to everolimus and add mirtazapine", "Administer brincidofovir and intravenous immunoglobuli", "Empiric treatment with pyrimethamine/sulfadiazine for toxoplasmosis"], "answer": "C", "answer_index": 2, "explanation": "This is progressive multifocal leukoencephalopathy (PML) in an immunocompromised host. The cornerstone is reducing immunosuppression, specifically switching from mycophenolate (which strongly inhibits T-cell function) to everolimus (which has anti-neoplastic properties and may slow PML progression). Mirtazapine has shown potential benefit by blocking 5-HT2A receptors that JC virus uses for entry. Cidofovir is ineffective against JC virus. Exchange transfusion is not indicated. Antitoxoplasma therapy would be incorrect with positive JC virus PCR.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Infectious Disease", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: C (Contradiction). Verdict: The stem contains irreconcilable imaging-pathology discordance that precludes selecting a unique best answer. Key discriminators—liver transplant immunosuppression, JC virus PCR positivity, and 'eccentric target sign'—point to mutually exclusive diagnoses: the target sign is pathognomonic for cerebral toxoplasmosis, whereas PML characteristically shows non-enhancing white matter lesions. While PML management centers on immunosuppression reduction, no option accurately reflects this standard. Option C is miskeyed; substituting mycophenolate with everolimus lacks evidence (both impair T-cell function), and mirtazapine remains experimental without guideline support. Option A correctly emphasizes immunosuppression reduction but inappropriately adds cidofovir, which is ineffective against JC virus. The contradictory imaging undermines the entire item, forcing learners to ignore critical data. Medical accuracy is further compromised by endorsing investigational therapy as 'most appropriate.' Minimal fix: Change MRI description to 'multifocal non-enhancing white matter lesions without mass effect' and revise option C to 'Reduce immunosuppression, specifically discontinue mycophenolate.'\",\"medical_accuracy_score\":  \t\"2\",\"logical_validity\":false,\"logical_false_reason\":\"C\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: C (Contradiction). Verdict: The stem contains irreconcilable imaging-pathology discordance that precludes selecting a unique best answer. Key discriminators—liver transplant immunosuppression, JC virus PCR positivity, and 'eccentric target sign'—point to mutually exclusive diagnoses: the target sign is pathognomonic for cerebral toxoplasmosis, whereas PML characteristically shows non-enhancing white matter lesions. While PML management centers on immunosuppression reduction, no option accurately reflects this standard. Option C is miskeyed; substituting mycophenolate with everolimus lacks evidence (both impair T-cell function), and mirtazapine remains experimental without guideline support. Option A correctly emphasizes immunosuppression reduction but inappropriately adds cidofovir, which is ineffective against JC virus. The contradictory imaging undermines the entire item, forcing learners to ignore critical data. Medical accuracy is further compromised by endorsing investigational therapy as 'most appropriate.' Minimal fix: Change MRI description to 'multifocal non-enhancing white matter lesions without mass effect' and revise option C to 'Reduce immunosuppression, specifically discontinue mycophenolate.'", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-011", "question": "A 34-year-old woman presents with progressive visual field loss. MRI reveals a large suprasellar mass extending into the third ventricle with homogeneous enhancement. Endoscopic biopsy shows a mixed glial and neuronal tumor with neurocytic rosettes and perivascular pseudorosettes. Genetic analysis demonstrates BRAF V600E mutation. What is the most appropriate surgical strategy?", "options": ["Attempt gross total resection via endoscopic endonasal approach", "Subtotal resection followed by targeted BRAF inhibitor therapy", "Open craniotomy with interhemispheric transcallosal approach", "Lateral ventricle endoscopic resection with third ventriculostomy", "Stereotactic biopsy followed by conformal radiotherapy"], "answer": "B", "answer_index": 1, "explanation": "The histology describes a papillary glioneuronal tumor, a low-grade neoplasm with favorable prognosis. When BRAF V600E mutation is present, targeted therapy with BRAF inhibitors can achieve significant tumor reduction with less surgical morbidity compared to aggressive resection for this deeply located tumor. Gross total resection risks hypothalamic injury given the suprasellar location. Radiotherapy is reserved for progressive disease after medical therapy. The transcallosal approach would provide inadequate exposure for this primarily suprasellar lesion.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: M (Multiple answers defensible). The vignette describes a BRAF-mutated papillary glioneuronal tumor (PGNT) in a challenging suprasellar location. While subtotal resection + BRAF inhibitor (key B) is a reasonable emerging strategy, gross total resection (Option A) remains the oncologic gold standard for low-grade tumors and is defensible via endoscopic endonasal approach. The stem lacks critical discriminating details: relationship to hypothalamus/optic chiasm, degree of invasiveness, and surgeon's assessment of resectability. Both A and B are clinically justifiable, making the item ambiguous. The question also improperly frames a combined surgical-medical strategy as a 'surgical strategy.' Medical accuracy is compromised by presenting targeted therapy as the preferred approach rather than as an alternative for unresectable disease, which misrepresents current standard of care where maximal safe resection is prioritized. Minor terminology issue: 'neurocytic rosettes' is not classic PGNT terminology (rosettes are typical, but 'neurocytic' is less standard). Fix: Specify 'tumor adherent to hypothalamus making gross total resection unsafe' to justify subtotal resection + adjuvant strategy, or change question to ask for 'overall management' rather than 'surgical strategy.'\",\"medical_accuracy_score\":  \"3\",\"logical_validity\": false,\"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: M (Multiple answers defensible). The vignette describes a BRAF-mutated papillary glioneuronal tumor (PGNT) in a challenging suprasellar location. While subtotal resection + BRAF inhibitor (key B) is a reasonable emerging strategy, gross total resection (Option A) remains the oncologic gold standard for low-grade tumors and is defensible via endoscopic endonasal approach. The stem lacks critical discriminating details: relationship to hypothalamus/optic chiasm, degree of invasiveness, and surgeon's assessment of resectability. Both A and B are clinically justifiable, making the item ambiguous. The question also improperly frames a combined surgical-medical strategy as a 'surgical strategy.' Medical accuracy is compromised by presenting targeted therapy as the preferred approach rather than as an alternative for unresectable disease, which misrepresents current standard of care where maximal safe resection is prioritized. Minor terminology issue: 'neurocytic rosettes' is not classic PGNT terminology (rosettes are typical, but 'neurocytic' is less standard). Fix: Specify 'tumor adherent to hypothalamus making gross total resection unsafe' to justify subtotal resection + adjuvant strategy, or change question to ask for 'overall management' rather than 'surgical strategy.'", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-012", "question": "A 72-year-old man with metastatic castration-resistant prostate cancer to bones undergoes palliative radiotherapy to a symptomatic lumbar spine metastasis (8 Gy × 1). Two weeks later, he develops sudden onset bilateral lower extremity weakness and numbness. MRI shows new T2 hyperintensity in the thoracolumbar cord extending beyond the radiation field. What is the most likely diagnosis?", "options": ["Radiation myelopathy", "Leptomeningeal carcinomatosis", "Paraneoplastic myelitis associated with anti-amphiphysin antibodies", "Spinal cord infarction from tumor embolus", "Subacute combined degeneration from B12 deficiency"], "answer": "C", "answer_index": 2, "explanation": "This presentation describes a paraneometric myelitis triggered by radiation-induced tumor cell death releasing antigens, not direct radiation toxicity (which occurs after longer latency and respects radiation fields). Prostate cancer is associated with anti-amphiphysin antibodies that can cause myelitis. Leptomeningeal disease would show enhancement on MRI. Radiation myelopathy typically presents 6-24 months post-treatment. Cord infarction would have acute dramatic onset rather than subacute progression.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: C (Contradiction). Verdict: Not uniquely determinable. The stem describes 'sudden onset' weakness 2 weeks after palliative radiation, while the rationale characterizes this as 'subacute progression,' creating irreconcilable temporal ambiguity that prevents distinguishing spinal cord infarction (Option D) from inflammatory etiologies. Key discriminating clues—T2 hyperintensity beyond the radiation field and 2-week latency—are insufficient because MRI lacks critical details (enhancement pattern, diffusion restriction). Medical accuracy is compromised: anti-amphiphysin antibodies are not established prostate cancer-associated paraneoplastic markers, and radiation-triggered paraneoplastic myelitis is speculative, not standard teaching. This forces reliance on a non-evidence-based mechanism. Options A and B are reasonably excluded based on latency and field extension, but the contradiction between stem and rationale makes D defensible if 'sudden onset' is interpreted literally. Minimal fix: Revise stem to specify precise symptom onset (hours vs days) and change option C to a recognized entity (e.g., acute radiation-induced demyelination) with accurate pathophysiology.\",\"medical_accuracy_score\":   \"2\",\"logical_validity\": false,\"logical_false_reason\": \"C\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: C (Contradiction). Verdict: Not uniquely determinable. The stem describes 'sudden onset' weakness 2 weeks after palliative radiation, while the rationale characterizes this as 'subacute progression,' creating irreconcilable temporal ambiguity that prevents distinguishing spinal cord infarction (Option D) from inflammatory etiologies. Key discriminating clues—T2 hyperintensity beyond the radiation field and 2-week latency—are insufficient because MRI lacks critical details (enhancement pattern, diffusion restriction). Medical accuracy is compromised: anti-amphiphysin antibodies are not established prostate cancer-associated paraneoplastic markers, and radiation-triggered paraneoplastic myelitis is speculative, not standard teaching. This forces reliance on a non-evidence-based mechanism. Options A and B are reasonably excluded based on latency and field extension, but the contradiction between stem and rationale makes D defensible if 'sudden onset' is interpreted literally. Minimal fix: Revise stem to specify precise symptom onset (hours vs days) and change option C to a recognized entity (e.g., acute radiation-induced demyelination) with accurate pathophysiology.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-013", "question": "A 58-year-old man undergoes left lower lobectomy for stage IIA NSCLC. On postoperative day 2, he develops productive cough and low-grade fever. Chest tube output increases to 450 mL/day of serosanguinous fluid. Fluid analysis shows pH 7.25, glucose 45 mg/dL, LDH 485 U/L. What is the most appropriate management?", "options": ["Insertion of a second chest tube", "Immediate return to operating room for exploration", "Initiation of broad-spectrum antibiotics alone", "Video-assisted thoracoscopic drainage and pleural irrigation", "Observation with repeat chest radiograph in 24 hours"], "answer": "D", "answer_index": 3, "explanation": "The fluid characteristics (low pH, low glucose, elevated LDH) indicate an early empyema or complicated parapneumonic effusion. VATS allows direct visualization, breakdown of loculations, thorough irrigation, and precise tube placement. A second chest tube may not address localized infection. Reoperation is premature without attempted minimally invasive drainage. Antibiotics alone won't drain the infected space. Observation risks progression to fibrinopurulent stage.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Thoracic Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Keyed answer D is the correct best answer. The post-lobectomy patient on POD 2 with fever, productive cough, and increased chest tube output has pleural fluid diagnostic of complicated parapneumonic effusion (pH 7.25, glucose 45 mg/dL, LDH 485 U/L). The critical clue is low pH despite existing drainage, indicating loculated infection requiring definitive intervention. VATS drainage and irrigation directly addresses this by enabling visualization, breaking down loculations, and thorough lavage—superior to simple tube thoracostomy. Alternative critique: A second chest tube (A) would not overcome loculations; immediate reoperation (B) is excessively invasive; antibiotics alone (C) are insufficient without drainage; observation (E) risks fibrinopurulent organization. No internal contradictions exist, and options are discriminating. Medical accuracy aligns with ATS/IDSA guidelines for empyema management. Minor limitation: the stem does not explicitly describe imaging findings or confirm the existing tube is malpositioned, but the fluid analysis alone justifies VATS. Minimal fix: None required; item is board-caliber.\",\"medical_accuracy_score\":  \t\"4\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Keyed answer D is the correct best answer. The post-lobectomy patient on POD 2 with fever, productive cough, and increased chest tube output has pleural fluid diagnostic of complicated parapneumonic effusion (pH 7.25, glucose 45 mg/dL, LDH 485 U/L). The critical clue is low pH despite existing drainage, indicating loculated infection requiring definitive intervention. VATS drainage and irrigation directly addresses this by enabling visualization, breaking down loculations, and thorough lavage—superior to simple tube thoracostomy. Alternative critique: A second chest tube (A) would not overcome loculations; immediate reoperation (B) is excessively invasive; antibiotics alone (C) are insufficient without drainage; observation (E) risks fibrinopurulent organization. No internal contradictions exist, and options are discriminating. Medical accuracy aligns with ATS/IDSA guidelines for empyema management. Minor limitation: the stem does not explicitly describe imaging findings or confirm the existing tube is malpositioned, but the fluid analysis alone justifies VATS. Minimal fix: None required; item is board-caliber.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-014", "question": "A 68-year-old woman with a history of thoracic endovascular aortic repair (TEVAR) for descending aortic aneurysm presents with hoarseness and dysphagia. Barium swallow shows external compression of the esophagus without mucosal abnormality. Which management strategy addresses the most likely etiology while minimizing procedural risk?", "options": ["Revision TEVAR with proximal extension", "Direct laryngoscopy with vocal cord medialization", "Esophageal stent placement", "CT angiography of the chest with 3D reconstruction", "Open surgical aneurysm repair via left thoracotomy"], "answer": "D", "answer_index": 3, "explanation": "Hoarseness suggests recurrent laryngeal nerve palsy, and dysphagia indicates mechanical compression-findings consistent with a newly enlarging aortic aneurysm at the TEVAR landing zone causing mass effect. CTA provides definitive evaluation of aneurysm size and relationship to adjacent structures. Endoscopy may show compression but cannot characterize the extracesophageal cause. Revision TEVAR or open repair would be premature without demonstrating aneurysm growth. Mere observation misses the opportunity for timely intervention if expansion is confirmed.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Vascular Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Keyed answer is correct best answer. Key stem clues: Post-TEVAR status, hoarseness (recurrent laryngeal nerve palsy), dysphagia, and external esophageal compression on barium swallow indicate mass effect from an enlarging thoracic aortic aneurysm or TEVAR complication. CT angiography with 3D reconstruction (Option D) is the definitive, non-invasive diagnostic study to evaluate aneurysm size and relationship to adjacent structures, directly addressing the suspected etiology while minimizing procedural risk. Options A and E are premature and high-risk without imaging confirmation. Option B treats only vocal cord paralysis symptomatically. Option C incorrectly targets esophageal stenting for extrinsic compression and could be hazardous. No logical contradictions; a single best answer is clear. Medical accuracy is sound: CTA is guideline-recommended for suspected TEVAR complications. The rationale correctly emphasizes that observation would miss timely intervention opportunity. Minimal fix: Clarify stem to 'next best step in management' to explicitly frame the diagnostic choice, though current phrasing is standard board style.\",\"medical_accuracy_score\":  \t\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Keyed answer is correct best answer. Key stem clues: Post-TEVAR status, hoarseness (recurrent laryngeal nerve palsy), dysphagia, and external esophageal compression on barium swallow indicate mass effect from an enlarging thoracic aortic aneurysm or TEVAR complication. CT angiography with 3D reconstruction (Option D) is the definitive, non-invasive diagnostic study to evaluate aneurysm size and relationship to adjacent structures, directly addressing the suspected etiology while minimizing procedural risk. Options A and E are premature and high-risk without imaging confirmation. Option B treats only vocal cord paralysis symptomatically. Option C incorrectly targets esophageal stenting for extrinsic compression and could be hazardous. No logical contradictions; a single best answer is clear. Medical accuracy is sound: CTA is guideline-recommended for suspected TEVAR complications. The rationale correctly emphasizes that observation would miss timely intervention opportunity. Minimal fix: Clarify stem to 'next best step in management' to explicitly frame the diagnostic choice, though current phrasing is standard board style.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-015", "question": "A 47-year-old woman with situs inversus totalis presents with recurrent episodes of acute pancreatitis. MRCP shows pancreas divisum with Santorinicole in the dorsal duct. Previous minor papilla sphincterotomy provided only temporary relief. What is the most appropriate definitive management?", "options": ["Total pancreatectomy with islet autotransplantation", "Long-term pancreatic stent placement across the minor papilla", "Endoscopic ultrasound-guided gastroenterostomy creation", "Surgical dorsal duct jejunostomy (Puestow procedure)", "Repeat ERCP with extended sphincterotomy and stricture dilation"], "answer": "A", "answer_index": 0, "explanation": "In the setting of situs inversus with complex pancreatic duct anatomy (Santorinicole) and failed sphincterotomy, TP-IAT offers the only definitive solution for recurrent pancreatitis while preserving endocrine function. The anomalous anatomy makes standard drainage procedures (Puestow) technically challenging and less effective. Long-term stenting leads to ductal changes and strictures. EUS-guided drainage would not address the underlying drainage impairment from the Santorinicole.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: K (Miskeyed). Verdict: The keyed answer A (TP-IAT) is not the best answer. Key stem clues: 47-year-old woman, situs inversus totalis, recurrent acute pancreatitis, pancreas divisum with Santorinicole, prior minor papilla sphincterotomy gave only temporary relief. The question asks for the most appropriate definitive management. TP-IAT is a major operation indicated for chronic pancreatitis with intractable pain and endocrine insufficiency, not for recurrent acute pancreatitis without chronic changes. Standard definitive options after failed sphincterotomy include surgical dorsal duct drainage (Puestow) or minor papilla sphincteroplasty. The Puestow (option D) directly addresses the obstructed dorsal duct and is the accepted surgical drainage procedure for chronic pancreatitis with a dilated duct; it is appropriate here. Long-term stenting (B) is discouraged due to ductal injury, EUS-guided gastroenterostomy (C) is irrelevant, and repeat ERCP (E) is less definitive. The rationale incorrectly claims TP-IAT is the only definitive solution and misstates that situs inversus makes Puestow technically unfeasible. Minimal fix: Change the key to D and revise the rationale to endorse dorsal duct jejunostomy as the definitive drainage procedure.\",\n\"medical_accuracy_score\":   \t\"2\",\n\"logical_validity\": false,\n\"logical_false_reason\": \"K\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: The keyed answer A (TP-IAT) is not the best answer. Key stem clues: 47-year-old woman, situs inversus totalis, recurrent acute pancreatitis, pancreas divisum with Santorinicole, prior minor papilla sphincterotomy gave only temporary relief. The question asks for the most appropriate definitive management. TP-IAT is a major operation indicated for chronic pancreatitis with intractable pain and endocrine insufficiency, not for recurrent acute pancreatitis without chronic changes. Standard definitive options after failed sphincterotomy include surgical dorsal duct drainage (Puestow) or minor papilla sphincteroplasty. The Puestow (option D) directly addresses the obstructed dorsal duct and is the accepted surgical drainage procedure for chronic pancreatitis with a dilated duct; it is appropriate here. Long-term stenting (B) is discouraged due to ductal injury, EUS-guided gastroenterostomy (C) is irrelevant, and repeat ERCP (E) is less definitive. The rationale incorrectly claims TP-IAT is the only definitive solution and misstates that situs inversus makes Puestow technically unfeasible. Minimal fix: Change the key to D and revise the rationale to endorse dorsal duct jejunostomy as the definitive drainage procedure.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-016", "question": "A 52-year-old man with alcohol-related cirrhosis presents with acute upper GI bleeding. During emergent endoscopy, active spurting is seen from a large duodenal ulcer in the posterior bulb. After epinephrine injection and placement of two through-the-scope clips, bleeding continues. The following day, he develops fever and severe abdominal pain. CT shows retroperitoneal air and fluid tracking along the right psoas muscle. What is the most appropriate management?", "options": ["Angiographic embolization of the gastroduodenal artery", "Emergency laparotomy with duodenal diversion", "Percutaneous drainage of the retroperitoneal collection", "Repeat endoscopy with over-the-scope clip placement", "IV antibiotics and serial abdominal exams"], "answer": "B", "answer_index": 1, "explanation": "This scenario describes a posterior duodenal ulcer perforation into the retroperitoneum following endoscopic intervention. Given the ongoing bleeding and established contamination, definitive surgical management with duodenal diversion (e.g., Graham patch closure with gastrodujunostomy) is required. Angioembolization would address bleeding but not the perforation. Percutaneous drainage cannot control the duodenal leak. Repeat endoscopy is contraindicated with known perforation. Antibiotics alone would lead to uncontrolled sepsis.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. Key stem clues: posterior duodenal ulcer, failed endoscopic hemostasis with active spurting, new fever/severe pain, CT showing retroperitoneal air/fluid along psoas—diagnostic of perforation with contamination. The question asks for most appropriate management of this surgical emergency. Option B (emergency laparotomy with duodenal diversion) is defensible as it addresses both ongoing bleeding risk and contaminated perforation. Alternatives are appropriately excluded: angiography (A) would miss perforation, percutaneous drainage (C) cannot control duodenal leak, repeat endoscopy (D) is contraindicated, and antibiotics alone (E) insufficient for source control. No internal contradictions exist; a single best surgical answer is identifiable. Medical accuracy is sound: posterior ulcers perforate retroperitoneally, failed endoscopy with perforation mandates surgery, and diversion is an accepted technique for severe cases. Minor nuance: stem doesn't explicitly confirm ongoing bleeding at time of surgery, but clinical trajectory implies it. Minimal fix: clarify in stem that patient remains hemodynamically unstable or that bleeding is suspected to be ongoing, to strengthen indication for diversion over simple repair.\",\"medical_accuracy_score\":   \t\"4\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. Key stem clues: posterior duodenal ulcer, failed endoscopic hemostasis with active spurting, new fever/severe pain, CT showing retroperitoneal air/fluid along psoas—diagnostic of perforation with contamination. The question asks for most appropriate management of this surgical emergency. Option B (emergency laparotomy with duodenal diversion) is defensible as it addresses both ongoing bleeding risk and contaminated perforation. Alternatives are appropriately excluded: angiography (A) would miss perforation, percutaneous drainage (C) cannot control duodenal leak, repeat endoscopy (D) is contraindicated, and antibiotics alone (E) insufficient for source control. No internal contradictions exist; a single best surgical answer is identifiable. Medical accuracy is sound: posterior ulcers perforate retroperitoneally, failed endoscopy with perforation mandates surgery, and diversion is an accepted technique for severe cases. Minor nuance: stem doesn't explicitly confirm ongoing bleeding at time of surgery, but clinical trajectory implies it. Minimal fix: clarify in stem that patient remains hemodynamically unstable or that bleeding is suspected to be ongoing, to strengthen indication for diversion over simple repair.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-017", "question": "A 35-year-old woman with tuberous sclerosis complex develops rapidly progressive renal insufficiency. Imaging shows massively enlarged kidneys with innumerable angiomyolipomas, the largest measuring 8 cm. What is the most appropriate intervention to preserve renal function?", "options": ["Selective arterial embolization of the dominant tumors", "Initiation of everolimus therapy", "Bilateral nephrectomy with dialysis initiation", "Cryoablation of the largest angiomyolipomas", "Radical nephrectomy of the more affected kidney"], "answer": "B", "answer_index": 1, "explanation": "In TSC with diffuse angiomyolipomatosis causing renal failure, everolimus (an mTOR inhibitor) is first-line therapy as it targets the underlying pathophysiology, can reduce tumor size by over 50%, and preserves renal function better than procedural interventions. Embolization or ablation would be impractical for innumerable tumors and could accelerate renal decline. Nephrectomy should be avoided unless absolutely necessary for hemorrhage control. Everolimus addresses the systemic nature of TSC renal involvement.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Nephrology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V (valid). Verdict: The keyed answer B is the correct best answer. Key stem clues: 35-year-old woman with tuberous sclerosis complex, rapidly progressive renal insufficiency, massively enlarged kidneys with innumerable angiomyolipomas, largest 8 cm. These findings indicate diffuse TSC-related renal disease causing renal failure. The question asks for the most appropriate intervention to preserve renal function. Everolimus, an mTOR inhibitor, is guideline-recommended first-line therapy for TSC-associated AMLs >3 cm or multiple lesions; it reduces tumor burden, risk of hemorrhage, and can stabilize or improve renal function. Alternative options are inferior: embolization or cryoablation are impractical for innumerable lesions and may worsen renal function; nephrectomy (radical or bilateral) removes functional renal tissue and is reserved for hemorrhage or malignancy, not for preservation of function. No internal contradictions; the stem provides sufficient detail to select a single best answer. Medical accuracy: The rationale aligns with 2012 TSC consensus guidelines and EXIST-2 trial data; everolimus is the preferred systemic therapy for diffuse AML disease. No major inaccuracies. Minimal fix: None required; the item is clear and accurate as written.\",\n\"medical_accuracy_score\":  \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (valid). Verdict: The keyed answer B is the correct best answer. Key stem clues: 35-year-old woman with tuberous sclerosis complex, rapidly progressive renal insufficiency, massively enlarged kidneys with innumerable angiomyolipomas, largest 8 cm. These findings indicate diffuse TSC-related renal disease causing renal failure. The question asks for the most appropriate intervention to preserve renal function. Everolimus, an mTOR inhibitor, is guideline-recommended first-line therapy for TSC-associated AMLs >3 cm or multiple lesions; it reduces tumor burden, risk of hemorrhage, and can stabilize or improve renal function. Alternative options are inferior: embolization or cryoablation are impractical for innumerable lesions and may worsen renal function; nephrectomy (radical or bilateral) removes functional renal tissue and is reserved for hemorrhage or malignancy, not for preservation of function. No internal contradictions; the stem provides sufficient detail to select a single best answer. Medical accuracy: The rationale aligns with 2012 TSC consensus guidelines and EXIST-2 trial data; everolimus is the preferred systemic therapy for diffuse AML disease. No major inaccuracies. Minimal fix: None required; the item is clear and accurate as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-018", "question": "A 6-month-old boy presents with recurrent sinopulmonary infections, failure to thrive, and absent lymph nodes on examination. Flow cytometry shows profoundly decreased T cells with normal B cell numbers. Mitogen proliferation assays show no response. Genetic testing reveals a missense mutation in the ORAI1 gene. What specific immunologic defect is present?", "options": ["Defective thymic epithelial development", "Impaired VDJ recombination in T cell receptors", "Absence of stores operated calcium entry", "Mutation in the ζ-chain-associated protein kinase", "Adenosine deaminase deficiency with metabolic toxicity"], "answer": "C", "answer_index": 2, "explanation": "ORAI1 encodes a calcium release-activated calcium channel essential for store-operated calcium entry (SOCE), which is critical for T cell activation, cytokine production, and immune function. Without SOCE, T cells cannot properly activate despite normal development, explaining the severe combined immunodeficiency presentation with normal lymphocyte numbers but functional impairment. This is distinct from recombination defects (RAG, Artemis) or metabolic deficiencies (ADA). The ORAI1 mutation specifically disrupts calcium signaling after T cell receptor engagement.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Immunology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V. The ORAI1 mutation directly implicates defective store-operated calcium entry (SOCE) as the specific immunologic defect, making option C uniquely correct. Key discriminating clues include the confirmed genetic diagnosis, absent lymph nodes, profoundly decreased T cells with normal B cells, and absent mitogen response. Option C correctly identifies the channelopathy mechanism despite minor grammatical imprecision ('stores operated' vs 'store-operated'). Alternative options are clearly inferior: A (defective thymic epithelial development) mismatches the genetic finding and would present as DiGeorge syndrome; B (impaired VDJ recombination) would affect both T and B cells due to RAG defects; D (ZAP-70 mutation) involves a different TCR signaling molecule; E (adenosine deaminase deficiency) is a metabolic defect with distinct pathophysiology and toxic metabolites. Minor medical accuracy issue: the stem's 'profoundly decreased T cells' is atypical for ORAI1 deficiency, which usually features normal counts with functional impairment, but this does not prevent selection of the single best answer. The item effectively tests knowledge of calcium signaling in T-cell activation. Minimal fix: revise option C to 'Defective store-operated calcium entry' and adjust stem to clarify that T cells are present but non-functional.\",\n\"medical_accuracy_score\":   \t\"4\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. The ORAI1 mutation directly implicates defective store-operated calcium entry (SOCE) as the specific immunologic defect, making option C uniquely correct. Key discriminating clues include the confirmed genetic diagnosis, absent lymph nodes, profoundly decreased T cells with normal B cells, and absent mitogen response. Option C correctly identifies the channelopathy mechanism despite minor grammatical imprecision ('stores operated' vs 'store-operated'). Alternative options are clearly inferior: A (defective thymic epithelial development) mismatches the genetic finding and would present as DiGeorge syndrome; B (impaired VDJ recombination) would affect both T and B cells due to RAG defects; D (ZAP-70 mutation) involves a different TCR signaling molecule; E (adenosine deaminase deficiency) is a metabolic defect with distinct pathophysiology and toxic metabolites. Minor medical accuracy issue: the stem's 'profoundly decreased T cells' is atypical for ORAI1 deficiency, which usually features normal counts with functional impairment, but this does not prevent selection of the single best answer. The item effectively tests knowledge of calcium signaling in T-cell activation. Minimal fix: revise option C to 'Defective store-operated calcium entry' and adjust stem to clarify that T cells are present but non-functional.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-019", "question": "A 30-year-old missionary presents with a slowly enlarging scalp lesion after returning from Bolivia. biopsy demonstrates lobulated granulomatous inflammation with rare 5-7 μm budding yeast. Culture on brain-heart infusion agar at 25°C shows cream-colored colonies that convert to yeast form at 37°C. What is the most appropriate antifungal therapy?", "options": ["Itraconazole for 6-12 months", "Amphotericin B lipid complex followed by itraconazole", "Voriconazole indefinitely", "Posaconazole with therapeutic drug monitoring", "Fluconazole for 3-6 months"], "answer": "A", "answer_index": 0, "explanation": "The presentation describes cutaneous granulomas caused by Paracoccidioides brasiliensis, endemic to Latin America. Itraconazole is first-line for non-severe disease, with 6-12 months treatment typically achieving cure. Amphotericin B is reserved for severe disseminated disease. Voriconazole has variable activity against Paracoccidioides. Fluconazole is less effective due to higher relapse rates. The dimorphic growth pattern and geographic history are classic for this infection.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Infectious Disease", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. The vignette presents classic mild cutaneous paracoccidioidomycosis (PCM) in a traveler to Bolivia. Key discriminating clues: dimorphic fungus demonstrating mold-to-yeast conversion at 37°C, yeast size 5-7 μm, lobulated granulomas, and endemic geography uniquely identify Paracoccidioides spp. A solitary scalp lesion without systemic symptoms signifies non-severe disease. Itraconazole for 6-12 months (Option A) is the unequivocal first-line therapy per WHO and IDSA guidelines for mild-moderate PCM, making it the single best answer. Alternative options are correctly positioned as inferior: amphotericin B (B) is reserved for severe disseminated disease; voriconazole (C) has unreliable activity and indefinite duration is inappropriate; posaconazole (D) is second-line for refractory cases; fluconazole (E) carries higher relapse rates and 3-6 months is insufficient. No internal contradictions exist, and options permit clear discrimination by disease severity and guideline hierarchy. Medical accuracy is excellent and current. No assumptions beyond standard exam conventions are required. Minimal fix: none; item is board-ready.\",\"medical_accuracy_score\":   \t\t\t\t\t\t\"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. The vignette presents classic mild cutaneous paracoccidioidomycosis (PCM) in a traveler to Bolivia. Key discriminating clues: dimorphic fungus demonstrating mold-to-yeast conversion at 37°C, yeast size 5-7 μm, lobulated granulomas, and endemic geography uniquely identify Paracoccidioides spp. A solitary scalp lesion without systemic symptoms signifies non-severe disease. Itraconazole for 6-12 months (Option A) is the unequivocal first-line therapy per WHO and IDSA guidelines for mild-moderate PCM, making it the single best answer. Alternative options are correctly positioned as inferior: amphotericin B (B) is reserved for severe disseminated disease; voriconazole (C) has unreliable activity and indefinite duration is inappropriate; posaconazole (D) is second-line for refractory cases; fluconazole (E) carries higher relapse rates and 3-6 months is insufficient. No internal contradictions exist, and options permit clear discrimination by disease severity and guideline hierarchy. Medical accuracy is excellent and current. No assumptions beyond standard exam conventions are required. Minimal fix: none; item is board-ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "question_id": "20251216T183904770Z_deepseek-v3.2_seed130-020", "question": "A 42-year-old woman with HIV (CD4 180 cells/μL, viral load undetectable on ART) presents with 2 weeks of progressive neurological decline. MRI shows multiple ring-enhancing lesions with minimal edema. CSF PCR is negative for JC virus, toxoplasma, and CMV. Brain biopsy reveals necrotizing encephalitis with bizarre astrocytes and intranuclear viral inclusions. What is the most appropriate treatment?", "options": ["High-dose ganciclovir", "Intravenous foscarnet", "Artemisinin combination therapy", "Pyrimethamine plus sulfadiazine", "Cidofovir with probenecid"], "answer": "B", "answer_index": 1, "explanation": "The histopathological findings are characteristic of cytomegalovirus encephalitis, which can present with atypical MRI findings in immunocompromised hosts. Foscarnet is preferred over ganciclovir in this scenario because CMV encephalitis in HIV patients often occurs despite undetectable plasma viral loads, suggesting possible ganciclovir resistance or poor CNS penetration. Foscarnet has different mechanisms of action and better CNS penetration. The negative CSF PCR does not rule out CMV encephalitis due to low viral loads. Arteminsinin and anti-toxoplasma therapies would not address CMV.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Infectious Disease", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: U (underspecified). Verdict: Not uniquely determinable. The stem describes necrotizing encephalitis with bizarre astrocytes and intranuclear viral inclusions, a pattern that can be seen in both CMV and JC virus (PML) infections. The negative CSF JC PCR does not definitively exclude PML, and the MRI findings of multiple ring-enhancing lesions are atypical for CMV. Without a specific viral identification (e.g., immunohistochemistry or biopsy PCR confirming CMV), the diagnosis is ambiguous. Consequently, the answer choices, which target CMV (ganciclovir, foscarnet, cidofovir) or toxoplasma (pyrimethamine+sulfadiazine), do not align with a clear pathogen. The keyed answer B (foscarnet) assumes CMV encephalitis, but standard therapy is high-dose ganciclovir; foscarnet is reserved for resistance or intolerance. Thus the item is medically inaccurate. Minimal fix: state that biopsy immunostaining confirms CMV (e.g., positive CMV immediate-early antigen) and that ganciclovir resistance is suspected, making foscarnet the preferred agent. This would resolve underspecification and align the key with current guidelines.\",\n\"medical_accuracy_score\":  \t\t \t\"2\",\n\"logical_validity\": false,\n\"logical_false_reason\": \"U\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (underspecified). Verdict: Not uniquely determinable. The stem describes necrotizing encephalitis with bizarre astrocytes and intranuclear viral inclusions, a pattern that can be seen in both CMV and JC virus (PML) infections. The negative CSF JC PCR does not definitively exclude PML, and the MRI findings of multiple ring-enhancing lesions are atypical for CMV. Without a specific viral identification (e.g., immunohistochemistry or biopsy PCR confirming CMV), the diagnosis is ambiguous. Consequently, the answer choices, which target CMV (ganciclovir, foscarnet, cidofovir) or toxoplasma (pyrimethamine+sulfadiazine), do not align with a clear pathogen. The keyed answer B (foscarnet) assumes CMV encephalitis, but standard therapy is high-dose ganciclovir; foscarnet is reserved for resistance or intolerance. Thus the item is medically inaccurate. Minimal fix: state that biopsy immunostaining confirms CMV (e.g., positive CMV immediate-early antigen) and that ganciclovir resistance is suspected, making foscarnet the preferred agent. This would resolve underspecification and align the key with current guidelines.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 2}]